Lyme Disease Research Clinical Trials

Dr. Daniel Cameron, an internist and epidemiologist, has been actively involved in clinical research as a principle investigator in the tick-borne illness field and as a sub-investigator for leading pharmaceutical companies. Several of his key research projects are listed below.


REACH Program
An International Prospective Observational Registry in Subjects at Risk of Atherothrombotic Events


Multi-center Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin TDS


Migraine Therapy Evaluation Protocol
Multi-center, Open-label, Crossover Study Comparing Maxalt with Usual Care
Oral Migraine Medication

Daniel Cameron, M.D., M.P.H.

Investigator – Pfizer Gemini Study
Combination Norvasc and Lipitor
Phase IIIb Open-label, multi-center trial

Daniel Cameron, M.D., M.P.H.

Sub-investigator – Lyme Disease Retreatment Study
Mt. Sinai School of Medicine


Wound and soft tissue infection

Eli Lilly

Streptococcal pharyngitis
Uncomplicated urinary tract infection
Wound and soft tissue infection

G.D. Searle

Analgesic (phase I, II)


Generalized anxiety

Eli Lilly

Acute bronchitis


Lyme Disease



Overview of Lyme Disease Research

Overview of LDPR

In addition to his writing and clinical work, Dr. Cameron conducts epidemiological research through the Lyme Disease Practice & Research (LDPR) center, located at his private practice in Mount Kisco, New York …more  

Benefits of Lyme Disease Research

Benefits of Lyme Research

Through LDPR, patients gain access to clinical trials by the same doctors who are treating them, and they are often among the first to receive new, proven therapies for their disease. more  

Lyme Disease Published Papers

Published Papers

Dr. Daniel Cameron has published more than 30 scientific papers, covering a range of topics in the tick-borne disease field. Many papers have been featured in lectures in the United States, Europe and Canada …more